The effects of ERCC1 expression levels on the chemosensitivity of gastric cancer cells to platinum agents and survival in gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy

Excision repair cross-complementing 1 (ERCC1) is reported to be involved in the sensitivity of cancer cells to platinum-based chemotherapy. The present study was designed to evaluate the effects of ERCC1 expression on the chemosensitivity of platinum agents in gastric cancer cell lines, and on survi...

Descripción completa

Detalles Bibliográficos
Autores principales: LIU, YONG-PING, LING, YANG, QI, QIU-FENG, ZHANG, YA-PING, ZHANG, CHANG-SONG, ZHU, CHANG-TAI, WANG, MEI-HUA, PAN, YAO-DONG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576223/
https://www.ncbi.nlm.nih.gov/pubmed/23426424
http://dx.doi.org/10.3892/ol.2012.1096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576223/
https://www.ncbi.nlm.nih.gov/pubmed/23426424
http://dx.doi.org/10.3892/ol.2012.1096

Ejemplares similares